CBT and Medication Sequencing May Improve Treatment for Childhood Anxiety Disorders

Study Highlights Better Treatment Choices for Children and Teens With Anxiety

Anxiety disorders are among the most common mental health conditions affecting children and teenagers. Many young people experience persistent fears, excessive worry, avoidance behaviors, and difficulties at school, home, and in social situations. Finding the most effective treatment approach has been a major goal for clinicians and researchers because families often face an important question: Should treatment begin with therapy or medication?

A new randomized clinical trial published in the American Journal of Psychiatry provides valuable insight into this decision. The study examined whether children and adolescents with anxiety disorders benefit more from starting with exposure-based cognitive behavioral therapy (CBT), the medication fluoxetine, or a combination of both treatments over time.

The research, titled “A Pragmatic SMART Study of Medication and CBT Sequencing in Pediatric Anxiety Disorders: A Randomized Clinical Trial,” explored not only which treatment works best first, but also what clinicians should do when symptoms continue after an initial treatment period.

Understanding the Study Design

Researchers conducted a 24-week sequential multiple assignment randomized trial, known as a SMART study. This type of research design allows scientists to test different treatment pathways and determine whether changing strategies based on a child’s response leads to better outcomes.

The study included 316 children and teenagers between the ages of 8 and 17 who had significant anxiety symptoms and a diagnosed anxiety disorder. Participants were treated in community clinics, pediatric settings, and mental health centers, making the results more representative of real-world patients than many previous clinical studies.

At the beginning of the study, participants were randomly assigned to receive either:

• Exposure-based CBT, a therapy that helps children gradually face fears and develop coping skills
• Fluoxetine, a commonly used selective serotonin reuptake inhibitor (SSRI) medication for anxiety and depression

After 12 weeks, children who had not reached remission were assigned either to continue improving their original treatment or to add the second treatment approach.

For example, a child receiving CBT could either continue CBT or add fluoxetine. A child receiving medication could either continue medication or add CBT.

CBT and Medication Both Reduced Anxiety Symptoms

The main finding was that both CBT and fluoxetine helped reduce anxiety symptoms. Researchers found no significant difference between starting with therapy or starting with medication when looking at children’s own reports of anxiety symptoms after 24 weeks.

Overall, anxiety symptoms decreased by approximately 32% during the study period. Functional difficulties related to anxiety also improved, meaning many children experienced better daily functioning at school, home, and in social settings.

These findings suggest that families and clinicians have more than one effective starting option. The best first choice may depend on individual needs, treatment availability, family preferences, cost, and possible medication concerns.

Why Treatment Order May Matter

Although the overall differences between treatments were small, researchers found interesting patterns when looking at treatment sequences.

Children who began with CBT and later added medication showed some of the strongest improvements across several measures. This approach appeared especially helpful for reducing the impact of anxiety on daily life.

The findings suggest that learning anxiety management skills through CBT before adding medication may benefit some children, particularly those who continue experiencing symptoms after several months of therapy.

However, the study also found differences among groups of children. Some non-Hispanic White youths appeared to benefit more from beginning with fluoxetine and continuing medication. In contrast, racial and ethnic minority youths showed greater improvement when combination treatment was introduced.

Researchers noted that future studies are needed to better understand why certain groups may respond differently to specific treatment approaches.

CBT May Require More Time to Show Benefits

One important observation from the study was that CBT improvements developed gradually.

During the first 12 weeks, medication appeared to provide faster symptom improvement according to some parent reports. However, by 24 weeks, CBT outcomes were similar or sometimes better in certain areas.

This finding is important because families and clinicians may sometimes judge therapy too quickly. Exposure-based CBT requires active participation and practice, and meaningful improvements may take longer to appear.

The results suggest that children receiving CBT may need enough time to complete the treatment process before deciding whether it has been effective.

Side Effects and Treatment Safety

Both treatments were generally well tolerated. Serious adverse events were uncommon throughout the study.

The main difference was that children receiving fluoxetine reported reduced appetite more frequently than those receiving CBT. This finding highlights the importance of monitoring possible medication effects while also considering the benefits of symptom improvement.

CBT did not involve medication risks, but it does require time, commitment, and access to trained therapists. In many areas, finding qualified CBT providers can be challenging.

What This Means for Families

For parents deciding how to help a child with anxiety, this study provides reassurance that multiple evidence-based treatments can work.

There is no single treatment approach that is ideal for every child. Factors that may influence the best choice include:

• The severity of anxiety symptoms
• The child’s preferences and comfort level
• Availability of trained CBT providers
• Previous treatment experiences
• Other mental health conditions
• Family circumstances and resources

Children who prefer learning coping skills and facing fears directly may benefit from CBT. Others may prefer medication, especially when symptoms are severe or interfere significantly with daily functioning.

For children who do not improve enough after an initial treatment period, adding another treatment method may provide additional benefits.

The Importance of Real-World Research

One strength of this study is that it included a diverse group of young people with more complex mental health needs than many earlier trials. Participants included children with additional challenges such as depression, attention difficulties, medical conditions, and socioeconomic disadvantages.

Because the study took place in community settings rather than only specialized research centers, the findings may better reflect what families experience in everyday healthcare.

Final Thoughts

Childhood anxiety disorders can significantly affect emotional health, relationships, education, and future wellbeing. This new research shows that both CBT and fluoxetine can be effective options, and treatment decisions do not need to follow a single path.

For many children, the best approach may involve personalizing treatment based on symptoms, preferences, access, and response over time. Starting with CBT, medication, or eventually combining both approaches can all be reasonable strategies when guided by qualified healthcare professionals.

The study reinforces an important message: effective anxiety treatment is available, but finding the right approach may require patience, monitoring, and collaboration between children, families, and clinicians.

Sources

Peterson BS, West AE, Weersing VR, et al. “A Pragmatic SMART Study of Medication and CBT Sequencing in Pediatric Anxiety Disorders: A Randomized Clinical Trial.” American Journal of Psychiatry. DOI: 10.1176/appi.ajp.20251037.

Disclaimer

This article is for educational and informational purposes only. It does not replace professional medical advice, diagnosis, or treatment. Parents and caregivers should consult a qualified healthcare provider before making decisions about therapy or medication for a child or teenager.